Literature DB >> 12016217

Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase.

Carol A Chrestensen1, Thomas W Sturgill.   

Abstract

The carboxyl-terminal domain (CTD) of the p90 ribosomal S6 kinases (RSKs) is an important regulatory domain in RSK and a model for kinase regulation of FXXFXF(Y) motifs in AGC kinases. Its properties had not been studied. We reconstituted activation of the CTD in Escherichia coli by co-expression with active ERK2 mitogen-activated protein kinase (MAPK). GST-RSK2-(aa373-740) was phosphorylated in the P-loop (Thr(577)) by MAPK, accompanied by increased phosphorylation on the hydrophobic motif site, Ser(386). Activated GST-RSK2-(aa373-740) phosphorylates synthetic peptides based on Ser(386). The peptide RRQLFRGFSFVAK, which was termed CTDtide, was phosphorylated with K(m) and V(max) values of approximately 140 microm and approximately 1 micromol/min/mg, respectively. Residues Leu at p -5 and Arg at p -3 are important for substrate recognition, but a hydrophobic residue at p +4 is not. RSK2 CTD is a much more selective peptide kinase than MAPK-activated protein kinase 2. CTDtide was used to probe regulation of hemagglutinin-tagged RSK proteins immunopurified from epidermal growth factor-stimulated BHK-21 cells. K100A but not K451A RSK2 phosphorylates CTDtide, indicating a requirement for the CTD. RSK2-(aa1-389) phosphorylates the S6 peptide, and this activity is inactivated by S386A mutation, but RSK2-(aa1-389) does not phosphorylate CTDtide. In contrast, RSK2-(aa373-740) containing only the CTD phosphorylates CTDtide robustly. Thus, CTDtide is phosphorylated by the CTD but not the NH(2)-terminal domain (NTD). Epidermal growth factor activates the CTD and NTD in parallel. Activity of the CTD for peptide phosphorylation correlates with Thr(577) phosphorylation. CTDtide activity is constrained in full-length RSK2. Interestingly, mutation of the conserved lysine in the ATP-binding site of the NTD completely eliminates S6 kinase activity, but a similar mutation of the CTD does not completely ablate kinase activity for intramolecular phosphorylation of Ser(386), even though it greatly reduces CTDtide activity. The standard lysine mutation used routinely to study kinase functions in vivo may be unsatisfactory when the substrate is intramolecular or in a tight complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016217     DOI: 10.1074/jbc.M202663200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  A clickable inhibitor reveals context-dependent autoactivation of p90 RSK.

Authors:  Michael S Cohen; Haralambos Hadjivassiliou; Jack Taunton
Journal:  Nat Chem Biol       Date:  2007-01-28       Impact factor: 15.040

3.  Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2.

Authors:  Margarita Malakhova; Valentina Tereshko; Sung-Young Lee; Ke Yao; Yong-Yeon Cho; Ann Bode; Zigang Dong
Journal:  Nat Struct Mol Biol       Date:  2007-12-16       Impact factor: 15.369

4.  The C-terminal kinase and ERK-binding domains of Drosophila S6KII (RSK) are required for phosphorylation of the protein and modulation of circadian behavior.

Authors:  Michelle M Tangredi; Fanny S Ng; F Rob Jackson
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

Review 5.  Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases.

Authors:  Marie Cargnello; Philippe P Roux
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

6.  The RSK Inhibitor BIX02565 Limits Cardiac Ischemia/Reperfusion Injury.

Authors:  Xi Shi; Margaret M O'Neill; Scott MacDonnell; Paul S Brookes; Chen Yan; Bradford C Berk
Journal:  J Cardiovasc Pharmacol Ther       Date:  2015-06-30       Impact factor: 2.457

7.  MSK1 activity is controlled by multiple phosphorylation sites.

Authors:  Claire E McCoy; David G Campbell; Maria Deak; Graham B Bloomberg; J Simon C Arthur
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

8.  Analyses of the effects of Rck2p mutants on Pbs2pDD-induced toxicity in Saccharomyces cerevisiae identify a MAP kinase docking motif, and unexpected functional inactivation due to acidic substitution of T379.

Authors:  L Jiang; S Niu; K L Clines; D J Burke; T W Sturgill
Journal:  Mol Genet Genomics       Date:  2004-01-21       Impact factor: 3.291

9.  Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling.

Authors:  Ryan T Strachan; Douglas J Sheffler; Belinda Willard; Michael Kinter; Janna G Kiselar; Bryan L Roth
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

10.  Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.

Authors:  Margarita Malakhova; Igor Kurinov; Kangdong Liu; Duo Zheng; Igor D'Angelo; Jung-Hyun Shim; Valerie Steinman; Ann M Bode; Zigang Dong
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.